|
RWDD2A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.721300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.208330E-02 |
| Normal-vs-Stage2 |
7.732100E-02 |
| Normal-vs-Stage3 |
6.258000E-01 |
| Normal-vs-Stage4 |
6.449400E-01 |
| Stage1-vs-Stage2 |
4.494200E-01 |
| Stage1-vs-Stage3 |
5.127000E-01 |
| Stage1-vs-Stage4 |
1.364380E-01 |
| Stage2-vs-Stage3 |
3.585400E-01 |
| Stage2-vs-Stage4 |
1.260840E-01 |
| Stage3-vs-Stage4 |
4.831600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.547920E-02 |
| Normal-vs-AfricanAmerican |
1.017050E-03 |
| Normal-vs-Asian |
7.840000E-01 |
| Caucasian-vs-AfricanAmerican |
8.132000E-02 |
| Caucasian-vs-Asian |
3.667200E-01 |
| AfricanAmerican-vs-Asian |
1.459410E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.193620E-02 |
| Normal-vs-Female |
1.027690E-02 |
| Male-vs-Female |
6.020800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.667020E-01 |
| Normal-vs-Extreme_Weight |
4.343800E-01 |
| Normal-vs-Obese |
9.357500E-03 |
| Normal-vs-Extreme_Obese |
4.874200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.647400E-01 |
| Normal_Weight-vs-Obese |
2.875600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.048000E-01 |
| Extreme_Weight-vs-Obese |
4.385500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.687200E-01 |
| Obese-vs-Extreme_Obese |
3.990800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.587700E-02 |
| Normal-vs-Age(41-60Yrs) |
4.399000E-04 |
| Normal-vs-Age(61-80Yrs) |
5.077700E-02 |
| Normal-vs-Age(81-100Yrs) |
2.379800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.807200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.316800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.637590E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.107800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.841500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.676000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.69960999999441E-05 |
| Normal-VS-Type2 PRCC |
9.281600E-01 |
| Normal-VS-KIRP CIMP |
8.629200E-01 |
| Normal-VS-Unclassified PRCC |
2.607200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.826100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
4.761800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.286000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.327600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.861200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.746200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.486000E-01 |
| Normal-vs-N1 |
1.520040E-01 |
| Normal-vs-N2 |
8.391800E-02 |
| N0-vs-N1 |
2.289000E-01 |
| N0-vs-N2 |
1.927010E-01 |
| N1-vs-N2 |
2.212800E-01 |
|
|
